{"id":"W3171965251","doi":"10.1200/jco.2021.39.15_suppl.4539","title":"Quality of life, functioning, and symptoms in patients with previously treated locally advanced or metastatic urothelial carcinoma from EV-301: A randomized phase 3 trial of enfortumab vedotin versus chemotherapy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Discontinuation; Internal medicine; Docetaxel; Randomized controlled trial; Performance status; Oncology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002333868,0.001062977,0.001995859,0.0002765215,0.0004228568,0.0007835321,0.0006856011,0.001291261,0.004089343],"category_scores_gemma":[0.001521545,0.0004562085,0.001657511,0.0003313867,0.00104885,0.0007013524,0.0005185117,0.002239197,0.0005541162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008171522,"about_ca_system_score_gemma":0.001132106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006178595,"about_ca_topic_score_gemma":0.001588747,"domain_scores_codex":[0.9990516,0.0005750471,0.00005554728,0.0001116527,0.00007092921,0.0001351309],"domain_scores_gemma":[0.9989828,0.0002584298,0.000226312,0.00007793355,0.00004873028,0.0004057495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9571483,0.01734256,0.003691741,0.0003077466,0.000572519,0.00005622529,0.0000722629,0.0004643535,0.002636062,0.00006791787,0.0007016305,0.01693862],"study_design_scores_gemma":[0.7267122,0.2590596,0.01145822,0.00003009409,0.000381957,0.0001129149,0.00004840185,0.0007730901,0.0006056278,0.0001435428,0.0006548885,0.00001938608],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965064,0.0009776361,0.0001047886,0.0001879125,0.00008555289,0.001155742,0.0003609552,0.00001609591,0.0006049003],"genre_scores_gemma":[0.9953614,0.0005028465,0.0004089154,0.0004054574,0.000146463,0.001719275,0.0006926131,0.000006101811,0.0007569731],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004089343,"threshold_uncertainty_score":0.01368028,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08126607043643114,"score_gpt":0.4339966940640265,"score_spread":0.3527306236275953,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}